BlackRock, Inc. (BLK) 13D/13G Filings for ADC Therapeutics SA (ADCT)

BlackRock, Inc. 13D and 13G filings for ADC Therapeutics SA:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-03
6:10 pm
Purchase
2024-12-3113GADC Therapeutics SA
ADCT
BlackRock Inc.
BLK
5,011,857
5.200%
5,011,857increase
(New Position)
Filing